Septerna, Inc. (SEPN) stock
SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30163% above fair value
$38.61−0.59 (-1.51%)
Close on Nov 20, 2026Market cap $1.80BP/E –Yield –
Septerna free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Septerna's free cash flow for the twelve months ending Sep 30, 2026 was -$77.59M, down 175.2% year over year. For fiscal 2025 it was $109.67M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $109.67M | – |
| FY2024 | Dec 31, 2024 | -$69.57M | – |
| FY2023 | Dec 31, 2023 | -$41.60M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$13.90M | -108.2% |
| Q2 FY2026 | Jun 30, 2026 | -$22.18M | – |
| Q1 FY2026 | Mar 31, 2026 | -$26.47M | – |
| Q4 FY2025 | Dec 31, 2025 | -$15.05M | – |
| Q3 FY2025 | Sep 30, 2025 | $168.79M | – |
| Q2 FY2025 | Jun 30, 2025 | -$20.35M | – |
| Q1 FY2025 | Mar 31, 2025 | -$23.73M | – |
| Q4 FY2024 | Dec 31, 2024 | -$21.57M | – |
| Q3 FY2024 | Sep 30, 2024 | -$17.39M | – |
| Q2 FY2024 | Jun 30, 2024 | -$13.14M | – |
| Q1 FY2024 | Mar 31, 2024 | -$17.48M | – |
| Q4 FY2023 | Dec 31, 2023 | -$10.04M | – |
See a number that looks wrong?